Showing 1261-1270 of 1425 results for "".
- Pixium Vision: Date Scheduled for Decision on Adoption of a Sale Planhttps://modernod.com/news/pixium-vison-date-scheduled-for-decision-on-adoption-of-a-sale-plan/2482020/Pixium Vision SA announced that following a hearing on Monday, the Paris Commercial Court will issue its decision on January 16, 2024 on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings. In the event of the opening of judicial l
- Belkin Vision Announces FDA Clearance for the Eagle for Selective Laser Trabeculoplastyhttps://modernod.com/news/belkin-vision-announces-fda-clearance-for-the-eagle-device/2482005/Belkin Vision has received FDA 510(k) clearance for the Eagle device, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG laser intended for use in performing selective laser trabeculoplasty (SLT). Belkin describes the Eagle as the first and only contactless l
- Bausch + Lomb Launches enVista Aspire Monofocal and Toric IOLshttps://modernod.com/news/bausch-lomb-launches-envista-aspire-monofocal-and-toric-iols/2481897/Bausch + Lomb announced the launch of the enVista Aspire monofocal and toric IOLs in the United States. The enVista Aspire IOLs featured B+L's Intermediate Optimized (IO) optics, which are designed for a broader depth of focus, with the benefits of the enVista platform to address patient
- Atsena Therapeutics to Present Positive Phase 1/2 Clinical Trial Data of ATSN-101 for the Treatment of GUCY2D-Associated LCA1https://modernod.com/news/atsena-therapeutics-to-present-positive-phase-12-clinical-trial-data-of-atsn-101-for-the-treatment-of-gucy2d-associated-lca1/2481394/Atsena Therapeutics announced that positive interim data from the ongoing phase 1/2 clinical trial of ATSN-101 will be presented at the 46th Annual Macula Society Meeting, which is being held February 15-18 in Miami. This is an encore presentation of data that were presented as a l
- MeiraGTx’s Unveils Gene Therapy Manufacturing Facility in Shannon, Irelandhttps://modernod.com/news/meiragtxs-unveils-gene-therapy-manufacturing-facility-in-shannon-ireland/2481098/MeiraGTx Holdings will formally unveil its GMP manufacturing facility in Shannon, Ireland, with the Head of Irish Government, Micheál Martin, in attendance. The facility, online since earlier this year and stretching over 150,000 square feet, is the first commercial-scale ge
- Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimurahttps://modernod.com/news/iveric-bio-and-delsitech-enter-exclusive-agreement-for-development-of-sustained-release-zimura/2480948/Iveric bio and DelSiTech announced an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations of Zimura (avacincaptad pegol) using DelSiTech’s silica-based sustained release technology. Under the terms of the l
- NIH Researchers Discover New Genetic Eye Diseasehttps://modernod.com/news/nih-researchers-discover-new-genetic-eye-disease/2480909/Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula. Scientists report their findings on the novel macular dystrophy, which is yet to be named, in JAMA Ophthalmology. Macular dystrophies are disorders that usually cause central visual l
- Prevent Blindness and Aerie Pharmaceuticals Partner to Offer New Glaucoma Research Granthttps://modernod.com/news/prevent-blindness-and-aerie-pharmaceuticals-partner-to-offer-new-glaucoma-research-grant/2480868/Research to Prevent Blindness (RPB) and Aerie Pharmaceuticals are partnering to provide early- to mid-career vision scientists with opportunities to pursue glaucoma research of unusual significance and promise. RPB announced the launch the RPB/David L. Epstein Career Advancem
- More than 240 Exhibitors Commit to Vision Expo East 2022, Taking Place In-Person from March 31–April 3 at the Javits Centerhttps://modernod.com/news/more-than-240-exhibitors-commit-to-vision-expo-east-2022-taking-place-in-person-from-march-31-april-3-at-the-javits-center/2480582/The organizers of Vision Expo, The Vision Council and RX, share that more than 240 exhibitors have committed to Vision Expo East to-date. Vision Expo East 2022 will take place from March 31–April 3 at the Jacob Javits Center in New York City. &l
- NIH Study Traces Molecular Link From Gene to Late-Onset Retinal Degenerationhttps://modernod.com/news/nih-study-traces-molecular-link-from-gene-to-late-onset-retinal-degeneration/2480510/Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health, generated a “dise